- CA$105.59m
- CA$112.62m
- 20
- 52
- 36
- 28
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 4.62 | 4.41 | -21.6 | 20.8 | 119 |
Operating Profit | -4.62 | -4.41 | 21.6 | -20.8 | -119 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -4.52 | -4.26 | 21.6 | -20.8 | -120 |
Net Income After Taxes | -4.52 | -4.26 | 21.6 | -20.8 | -120 |
Net Income Before Extraordinary Items | |||||
Net Income | -4.52 | -4.26 | 21.6 | -20.8 | -120 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -4.52 | -4.26 | 21.6 | -20.8 | -120 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.007 | -0.005 | 0.015 | -0.004 | -0.085 |